Omega-3 fatty acid supplements prevented autoimmune diseases for 2 years after cessation, but vitamin D's effects tapered off, suggesting that continuous dosing is warranted.
The study represents the first evidence of a similar reduction in therapeutic response with both TNF inhibitors and non-TNF biologics in patients with RA and severe obesity.